AIM ImmunoTech Inc. (AIM)Healthcare | Biotechnology | Ocala, United States | NYSE American
0.26 USD
+0.01
(3.360%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.26 +0.00 (1.432%) ⇧ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:07 a.m. EDT
The immediate outlook is severely compromised by a brutal multi-year price collapse. The asset has endured five consecutive years of negative annual returns, culminating in a staggering 99.97% loss over the last nine years. This trajectory is not merely a correction; it is a structural implosion where the market has repeatedly rejected the business model, evidenced by the single positive year being an outlier in a sea of destruction. While the recent news of a trial enrollment milestone and a 42% price surge offers a fleeting glimmer of hope, the underlying fundamentals remain catastrophic. The company is burning through cash with negative operating margins and negative free cash flow, while the balance sheet shows significant debt relative to its tiny equity base. The negative gross margins indicate a product or cost structure that is fundamentally broken. Despite the optimistic analyst consensus and the recent financing activities, the business quality appears deteriorated beyond the point of recovery without a complete transformation. There is no income to cushion the blow, and the path to profitability remains obscured by deep losses. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.941461 |
| AutoTheta | 0.955198 |
| MSTL | 0.990195 |
| AutoARIMA | 1.012920 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 19% |
| H-stat | 3.58 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.001 |
| Excess Kurtosis | 1.08 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 50.633 |
| Revenue per Share | 0.014 |
| Market Cap | 7,866,249 |
| Forward P/E | -0.70 |
| Beta | 1.19 |
| Website | https://aimimmuno.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.89349174 |
| Address1 | 2,117 SW Highway 484 |
| All Time High | 973,035.9 |
| All Time Low | 0.19 |
| Ask | 0.256 |
| Ask Size | 500 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 897,450 |
| Average Daily Volume3 Month | 10,213,545 |
| Average Volume | 10,213,545 |
| Average Volume10Days | 897,450 |
| Beta | 1.193 |
| Bid | 0.2523 |
| Bid Size | 400 |
| Book Value | 0.267 |
| City | Ocala |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.2584 |
| Current Ratio | 2.109 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.2598 |
| Day Low | 0.25 |
| Debt To Equity | 50.633 |
| Display Name | AIM ImmunoTech |
| Earnings Call Timestamp End | 1,743,510,600 |
| Earnings Call Timestamp Start | 1,743,510,600 |
| Earnings Timestamp End | 1,743,510,600 |
| Earnings Timestamp Start | 1,743,510,600 |
| Ebitda | -10,734,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.17 |
| Enterprise To Revenue | 19.192 |
| Enterprise Value | 1,823,248 |
| Eps Current Year | -0.78 |
| Eps Forward | -0.37 |
| Eps Trailing Twelve Months | -0.73 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 352 480 4620 |
| Fifty Day Average | 0.2764 |
| Fifty Day Average Change | -0.018000007 |
| Fifty Day Average Change Percent | -0.06512304 |
| Fifty Two Week Change Percent | -89.349174 |
| Fifty Two Week High | 2.890398 |
| Fifty Two Week High Change | -2.631998 |
| Fifty Two Week High Change Percent | -0.91060054 |
| Fifty Two Week Low | 0.19 |
| Fifty Two Week Low Change | 0.068399996 |
| Fifty Two Week Low Change Percent | 0.35999998 |
| Fifty Two Week Range | 0.19 - 2.890398 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 837,178,200,000 |
| Float Shares | 27,686,821 |
| Forward Eps | -0.37 |
| Forward P E | -0.6983783 |
| Free Cashflow | -14,060,500 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 19 |
| Fullday Change | 0.00839999 |
| Fullday Change Percent | 3.36 |
| Fullday Price | 0.2621 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -0.23158 |
| Gross Profits | -22,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00535 |
| Held Percent Institutions | 0.03879 |
| Implied Shares Outstanding | 30,442,139 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,770,681,600 |
| Last Split Factor | 1,031:1000 |
| Long Business Summary | AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida. |
| Long Name | AIM ImmunoTech Inc. |
| Market | us_market |
| Market Cap | 7,866,249 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_97799 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -14,270,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,610,534 |
| Number Of Analyst Opinions | 2 |
| Open | 0.256 |
| Operating Cashflow | -14,374,000 |
| Operating Margins | -135.11539 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.71 |
| Phone | 352 448 7797 |
| Post Market Change | 0.003700018 |
| Post Market Change Percent | 1.4318955 |
| Post Market Price | 0.2621 |
| Post Market Time | 1,787,961,571 |
| Previous Close | 0.25 |
| Price Eps Current Year | -0.33128205 |
| Price Hint | 4 |
| Price To Book | 0.96779025 |
| Price To Sales Trailing12 Months | 82.80262 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.015 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 0.00839999 |
| Regular Market Change Percent | 3.36 |
| Regular Market Day High | 0.2598 |
| Regular Market Day Low | 0.25 |
| Regular Market Day Range | 0.25 - 0.2598 |
| Regular Market Open | 0.256 |
| Regular Market Previous Close | 0.25 |
| Regular Market Price | 0.2584 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 324,851 |
| Return On Assets | -0.82577 |
| Return On Equity | -23.82304 |
| Revenue Growth | 0.04 |
| Revenue Per Share | 0.014 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 30,442,139 |
| Shares Percent Shares Out | 0.0227 |
| Shares Short | 691,534 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,543,826 |
| Short Name | AIM ImmunoTech Inc. |
| Short Percent Of Float | 0.0228 |
| Short Ratio | 0.54 |
| Source Interval | 15 |
| State | FL |
| Symbol | AIM |
| Target High Price | 7.0 |
| Target Low Price | 1.5 |
| Target Mean Price | 4.25 |
| Target Median Price | 4.25 |
| Total Cash | 9,964,000 |
| Total Cash Per Share | 0.327 |
| Total Debt | 3,921,000 |
| Total Revenue | 95,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.73 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.74473006 |
| Two Hundred Day Average Change | -0.48633006 |
| Two Hundred Day Average Change Percent | -0.65302867 |
| Type Disp | Equity |
| Volume | 324,851 |
| Website | https://aimimmuno.com |
| Zip | 34,473 |